Terms: = Kidney tumors AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
22 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. β-Ionone represses renal cell carcinoma progression through activating lkb1/AMPK-triggered autophagy.
Hou T; Wang Y; Dan W; Wei Y; Liu B; Que T; Lei Y; Yu B; Zeng J; Fan Y; Li L
J Biochem Mol Toxicol; 2023 Jun; 37(6):e23331. PubMed ID: 36843289
[TBL] [Abstract] [Full Text] [Related]
3. Midkine noncanonically suppresses AMPK activation through disrupting the lkb1-STRAD-Mo25 complex.
Xia T; Chen D; Liu X; Qi H; Wang W; Chen H; Ling T; Otkur W; Zhang CS; Kim J; Lin SC; Piao HL
Cell Death Dis; 2022 Apr; 13(4):414. PubMed ID: 35487917
[TBL] [Abstract] [Full Text] [Related]
4. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
Hasanvand A
Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
[TBL] [Abstract] [Full Text] [Related]
5. Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway.
Mohanty SK; Satapathy A; Aggarwal A; Mishra SK; Sampat NY; Sharma S; Williamson SR
Mod Pathol; 2022 Mar; 35(3):361-375. PubMed ID: 34802045
[TBL] [Abstract] [Full Text] [Related]
6. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.
Aronson M; Swallow C; Govindarajan A; Semotiuk K; Cohen Z; Kaurah P; Velsher L; Ambus I; Buckley K; Forster-Gibson C; Meschino WS; Blumenthal A; Kim RH; Brar S
Curr Oncol; 2020 Apr; 27(2):e182-e190. PubMed ID: 32489267
[TBL] [Abstract] [Full Text] [Related]
7. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Lin J; Cao Y; Yu L; Lin L
Medicine (Baltimore); 2018 Sep; 97(39):e12336. PubMed ID: 30278510
[TBL] [Abstract] [Full Text] [Related]
8. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the lkb1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract] [Full Text] [Related]
9. Clinical, Pathologic, and Genetic Features of Wilms tumors With WTX Gene Mutation.
Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
[TBL] [Abstract] [Full Text] [Related]
10. GSK-3β controls autophagy by modulating lkb1-AMPK pathway in prostate cancer cells.
Sun A; Li C; Chen R; Huang Y; Chen Q; Cui X; Liu H; Thrasher JB; Li B
Prostate; 2016 Feb; 76(2):172-83. PubMed ID: 26440826
[TBL] [Abstract] [Full Text] [Related]
11. Novel mutations and role of the lkb1 gene as a tumor suppressor in renal cell carcinoma.
Yalniz Z; Tigli H; Tigli H; Sanli O; Dalay N; Buyru N
Tumour Biol; 2014 Dec; 35(12):12361-8. PubMed ID: 25179843
[TBL] [Abstract] [Full Text] [Related]
12. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress.
Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B
Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496
[TBL] [Abstract] [Full Text] [Related]
13. Underexpression of tumour suppressor lkb1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo.
Duivenvoorden WC; Beatty LK; Lhotak S; Hill B; Mak I; Paulin G; Gallino D; Popovic S; Austin RC; Pinthus JH
Br J Cancer; 2013 Feb; 108(2):327-33. PubMed ID: 23322200
[TBL] [Abstract] [Full Text] [Related]
14. The genetic basis of kidney cancer: a metabolic disease.
Linehan WM; Srinivasan R; Schmidt LS
Nat Rev Urol; 2010 May; 7(5):277-85. PubMed ID: 20448661
[TBL] [Abstract] [Full Text] [Related]
15. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.
Short JD; Houston KD; Dere R; Cai SL; Kim J; Johnson CL; Broaddus RR; Shen J; Miyamoto S; Tamanoi F; Kwiatkowski D; Mills GB; Walker CL
Cancer Res; 2008 Aug; 68(16):6496-506. PubMed ID: 18701472
[TBL] [Abstract] [Full Text] [Related]
16. The mTOR pathway and its role in human genetic diseases.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Mutat Res; 2008; 659(3):284-92. PubMed ID: 18598780
[TBL] [Abstract] [Full Text] [Related]
17. lkb1/stk11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
[TBL] [Abstract] [Full Text] [Related]
18. The tuberous sclerosis complex genes in tumor development.
Mak BC; Yeung RS
Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
[TBL] [Abstract] [Full Text] [Related]
19. Complexes between the lkb1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract] [Full Text] [Related]
20. [Genomic alterations in preneoplastic lesions].
Gemma A
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2451-7. PubMed ID: 12506466
[TBL] [Abstract] [Full Text] [Related]
[Next]
